GENCEPT 10 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Gencept 10, and what generic alternatives are available?
Gencept 10 is a drug marketed by Barr and Barr Labs and is included in two NDAs.
The generic ingredient in GENCEPT 10 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for GENCEPT 10?
- What are the global sales for GENCEPT 10?
- What is Average Wholesale Price for GENCEPT 10?
Summary for GENCEPT 10
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| DailyMed Link: | GENCEPT 10 at DailyMed |
US Patents and Regulatory Information for GENCEPT 10
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr | GENCEPT 10/11-21 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 072694-001 | Feb 28, 1992 | DISCN | No | No | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| Barr Labs | GENCEPT 10/11-28 | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 072697-001 | Feb 28, 1992 | DISCN | No | No | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
